HC SECURITIES & INVESTMENT ADVISED MINAPHARM PHARMACEUTICALS ON THE ACQUISITION OF AN ADDITIONAL 15.76% OF ITS SUBSIDIARY MINAPHARM PROBIOGEN
August 28th, 2018
– HC Securities & Investment has successfully acted as the exclusive financial advisor to Minapharm Pharmaceuticals and Chemical Industries S.A.E. (MIPH.CA) (www.minapharm.com) on the acquisition of an additional 15.76% of the share capital of its subsidiary Minapharm ProBioGen S.A.E., a company specialized in the R&D and manufacturing of biopharmaceuticals, in a transaction valued at EGP 95 Million. HC Brokerage acted as the broker for both the buyer and the seller.
Post the transaction, Minapharm Pharmaceuticals’ shareholding in Minapharm ProBioGen has increased to 75.01% from 59.25%.